What is Cross-Linking?
Cross-linking is a minimally invasive outpatient procedure for the treatment of progressive keratoconus. FDA approved epi-off cross-linking combines the use of prescription eye drops, Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution), and ultra-violet A (UVA) light from the KXL® system to create new collagen cross-links and leads to the stiffening of the cornea. The goal of the procedure is to stiffen the cornea to slow or prevent further progression of the condition and preserve your vision.
Passion and the art of treating keratoconus.
Appropriate diagnosis and management/treatment of keratoconus is time consuming and involves having access to all treatment modalities. Early diagnosis and treatment of progressive keratoconus involves having access to the gold standard pentacam tomographer, FDA approved phototrex, and FDA approved Avedro CXL treatment protocol.
Meet Our Visionaries
Ivan H. Garcia, M.D.
Chief Director of Medical & Surgical Services
Irwin Azman, O.D.,
Chief Director of Refractive and Contact Lens Services